Management of Addison's Disease Patient Hospitalized with Nausea and Vomiting
Immediately administer hydrocortisone 100 mg IV bolus and begin aggressive fluid resuscitation with 0.9% saline at 1 liter over the first hour—this patient is in or approaching adrenal crisis and treatment must not be delayed. 1, 2, 3
Immediate Laboratory Workup
Draw blood samples before administering hydrocortisone if possible, but never delay treatment waiting for results: 1, 2
- Serum cortisol and ACTH (cortisol <250 nmol/L with elevated ACTH confirms primary adrenal insufficiency) 2, 3
- Serum electrolytes (expect hyponatremia in ~90% of cases, hyperkalemia in ~50%) 2, 3
- Creatinine and BUN (typically elevated from prerenal azotemia due to volume depletion) 2
- Glucose (hypoglycemia more common in children but can occur in adults) 2
- Complete blood count 4
Additional labs to consider if etiology unknown:
- 21-hydroxylase autoantibodies (21OH-Ab) to confirm autoimmune Addison's disease (~85% of cases in Western populations) 4, 2, 3
- CT scan of adrenals if 21OH-Ab negative, to evaluate for hemorrhage, tumor, tuberculosis, or infiltrative processes 2, 3
Emergency Treatment Protocol
Initial Management (First Hour)
Glucocorticoid replacement: 1, 2, 3
- Hydrocortisone 100 mg IV bolus immediately
- This high dose provides both glucocorticoid and mineralocorticoid effects (saturates 11β-hydroxysteroid dehydrogenase type 2)
- Do not add fludrocortisone during acute crisis—the high-dose hydrocortisone provides adequate mineralocorticoid activity 2
- 0.9% isotonic saline 1 liter IV over first hour
- Continue with 3-4 liters total over 24-48 hours with frequent hemodynamic monitoring
- Monitor closely to avoid fluid overload
Ongoing Management (Next 24-48 Hours)
Continue hydrocortisone: 1, 2, 3
- 100-300 mg/day either as:
- Continuous IV infusion, OR
- Divided IV/IM boluses of 100 mg every 6-8 hours
- Serum electrolytes every 4-6 hours initially
- Blood pressure and hemodynamic status
- Urine output
- Mental status
Identify and treat precipitating cause: 4, 2
- Gastrointestinal illness is the most common trigger
- Infection (obtain cultures, start antibiotics if indicated)
- Medication non-compliance
- Trauma or surgical stress
Common Pitfalls to Avoid
- Never delay treatment for diagnostic confirmation—mortality increases with delayed intervention 1, 2, 3
- Do not assume absence of hyperkalemia excludes crisis—it's only present in 50% of cases 2, 3
- Do not start thyroid hormone replacement before adequate glucocorticoid replacement in patients with multiple hormone deficiencies, as this can trigger crisis 1, 2
- Even mild nausea/vomiting can precipitate crisis because patients cannot absorb oral medications when they need them most 2
Transition to Maintenance Therapy
Once the patient is stable and can tolerate oral intake (typically 1-3 days): 1, 2
Taper parenteral hydrocortisone to oral therapy: 1, 3
- Hydrocortisone 15-25 mg daily divided into 2-3 doses (preferred over longer-acting agents like prednisone)
- Weight-adjusted dosing: starting doses 15-20 mg for hydrocortisone 5
Restart fludrocortisone when hydrocortisone dose falls below 50 mg/day: 2, 6
- Usual dose: 0.1 mg daily (range 0.05-0.2 mg daily)
- Adjust based on blood pressure and electrolytes
- If hypertension develops, reduce to 0.05 mg daily 4, 6
Prevention of Future Crises
Patient education is paramount: 1, 2, 3
- Double or triple oral glucocorticoid doses during minor illness (fever, gastroenteritis, upper respiratory infection) 1, 2
- Use parenteral hydrocortisone during severe illness or inability to take oral medications 1, 2
- Provide emergency supplies including injectable hydrocortisone 1, 3
- Medical alert jewelry and emergency steroid card 1, 3
Arrange endocrinology follow-up: 1, 3
- Education on emergency injectables
- Annual monitoring of weight, blood pressure, electrolytes 4, 3
- Screen for other autoimmune conditions (especially hypothyroidism) 4
Investigate causes of recurrent crises: 2
- Chronic under-replacement with fludrocortisone
- Low salt consumption
- Poor medication compliance
- Underlying psychiatric disorders